Haemolytic and uremic syndrome in children;Syndrome hémolytique et urémique chez l'enfant

EMC - Pediatrie

Volumn 1, Issue 4, 2004, Pages 379-385

  Niaudet, P ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Acute renal failure in children; Chronic renal failure in children; Escherichia coli; Haemolytic and uremic syndrome

Indexed keywords

EID: 33645730085     PISSN: 17626013     EISSN: 17626013     Source Type: Journal    
DOI: 10.1016/j.emcped.2004.08.001     Document Type: Short Survey

References (53)

1. Andreoli SP, Trachtman H, Acheson DW, Siegler RL, Obrig TG. Hemolytic uremic syndrome: epidemiology, pathophysiology, and therapy. Pediatr Nephrol 2002;17:293-8.
2. Ault BH. Factor H and the pathogenesis of renal diseases. Pediatr Nephrol 2000;14:1045-53.
3. Bhimma R, Rollins NC, Coovadia HM, Adhikari M. Post-dysenteric hemolytic uremic syndrome in children during an epidemic of Shigella dysentery in Kwazulu/Natal. Pediatr Nephrol 1997;11:560-4.
4. Brandt J, Wong C, Mihm S, Roberts J, Smith J, Brewer E, et al. Invasive pneumococcal disease and hemolytic uremic syndrome. Pediatrics 2002;110(2Pt1):371-6.
5. Buddles MR, Donne RL, Richards A, Goodship J, Goodship TH. Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome. Am J Hum Genet 2000;66:1721-2.
6. Caprioli J, Bettinaglio P, Zipfel PF, Amadei B, Daina E, Gamba S, et al. The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20. J Am Soc Nephrol 2001;12:297-307.
7. Crump JA, Sulka AC, Langer AJ, Schaben C, Crielly AS, Gage R, et al. An outbreak of Escherichia coli O157: H7 infections among visitors to a dairy farm. N Engl J Med 2002;347:555-60.
8. Decludt B, Bouvet P, Mariani-Kurkdjian P, Grimont F, Grimont PA, Hubert B, et al. Haemolytic uraemic syndrome and Shiga toxin-producing Escherichia coli infection in children in France. The Societe de Nephrologie Pediatrique. Epidemiol Infect 2000;124:215-20.
9. Deschenes G, Veyradier A, Cloarec S, Benoit S, Desbois I, Gruel Y, et al. Plasma therapy in von Willebrand factor protease deficiency. Pediatr Nephrol 2002;17:867-70.
10. Ducloux D, Rebibou JM, Sernhoun-Ducloux S, Jarnali M, Fournier V, Bresson-Vautrin C, et al. Recurrence of hemolytic uremic syndrome in renal transplant recipients. Transplantation 1998;65:1405-7.
11. Ferraris JR, Ramirez JA, Ruiz S, Caletti MG, Vallejo G, Piantanida JJ, et al. Shiga toxin-associated hemolytic uremic syndrome: absence of recurrence after renal transplantation. Pediatr Nephrol 2002;17:809-14.
12. Fitzpatrick MM, Shah V, Trompeter RS, Dillon MJ, Barratt TM. Long-term renal outcome of childhood haemolytic uraemic syndrome. BMJ 1991;303:489-92.
13. Fitzpatrick MM, Walters MD, Trompeter RS, Dillon MJ, Barratt TM. Atypical (non-diarrhea-associated) hemolytic-uremic syndrome in childhood. J Pediatr 1993;122:532-7.
14. Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrie PA, Brenner B, et al. Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 1998;339:1578-84.
15. Gagnadoux MF, Habib R, Gubler MC, Bacri JL, Broyer M. Long-term (15-25 years) outcome of childhood hemolytic-uremic syndrome. Clin Nephrol 1996;46:39-41.
16. Gerber A, Karch H, Allerberger F, Verweyen HM, Zimmerhackl LB. Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study. J Infect Dis 2002;186:493-500.
17. Habib R, Levy M, Gagnadoux MF, Broyer M. Prognosis of the hemolytic uremic syndrome in children. Adv Nephrol 1982;11:99-128.
18. Habib R. Pathology of the hemolytic and uremic syndrome. In: Kaplan B, Trompeter R, Moake J, editors. Hemolytic uremic syndrome and thrombotic thrombocytopenic purpura. New York: Marcel Dekker; 1992. p. 315-53.
19. Kaplan BS, Leonard M. Autosomal dominant hemolytic uremic syndrome: variable phenotypes and transplant results. Pediatr Nephrol 2000;14:464-8.
20. Kaplan BS, Kaplan P. Hemolytic uremic syndrome in families. In: Kaplan B, Trompeter R, Moake J, editors. Hemolytic uremic syndrome and thrombotic thrombocytopenic purpura. New York: Marcel Dekker; 1992. p. 213-25.
21. Kaplan BS, Papadimitriou M, Brezin JH, Tomlanovich SJ, Zulkharnain. Renal transplantation in adults with autosomal recessive inheritance of hemolytic uremic syndrome. Am J Kidney Dis 1997;30:760-5.
22. Kaplan BS, Proesmans W. The hemolytic uremic syndrome of childhood and its variants. Semin Hematol 1987;24:48-160.
23. Kaplan BS. Haemolytic uremic syndrome with recurrent episodes: an important subset. Clin Nephrol 1977;8:495-8.
24. Kelles A, Van Dyck M, Proesmans W. Childhood haemolytic uraemic syndrome: long-term outcome and prognostic features. Eur J Pediatr 1994;153:38-42.
25. Kind T, Levy J, Lee M, Kaicker S, Nicholson JF, Kane SA. Cobalamin C disease presenting as hemolytic-uremic syndrome in the neonatal period. J Pediatr Hematol Oncol 2002;24:327-9.
26. Kojouri K, Vesely SK, George JN. Quinine-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: frequency, clinical features, and long-term outcomes. Ann Intern Med 2001;135:1047-51.
27. Kokame K, Matsumoto M, Soejima K, Yagi H, Ishizashi H, Funato M, et al. Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity. Proc Natl Acad Sci USA 2002;99:11902-7.
28. Levy GG, Nichols WC, Lian EC, Foroud T, McClintick JN, McGee BM, et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 2001;413:488-94.
29. Loirat C, Baudouin V, Sonsino E, Mariani-Kurdjian P, Elion J. Hemolytic-uremic syndrome in the child. Adv Nephrol 1993;22:141-68.
30. Loirat C, Niaudet P. The risk of recurrence of hemolytic uremic syndrome after renal transplantation in children. Pediatr Nephrol 2003;18:1095-101.
31. Loirat C, Sonsino E, Varga Moreno A, Pillion G, Mercier JC, Beaufils F, et al. Hemolytic-uremic syndrome: an analysis of the natural history and prognostic features. Acta Paediatr Scand 1984;73:505-14.
32. Loirat C, Taylor CM. Hemolytic-uremic syndromes. In: Avner E, Harmon W, Niaudet P, editors. Pediatric nephrology. Baltimore: Lippincott-Williams and Wilkins; 2003.
33. Moake J. Thrombotic microangiopathies. N Engl J Med 2002;347:589-600.
34. Nathanson S, Deschenes G. Prognosis of Streptococcus pneumoniae-induced hemolytic uremic syndrome. Pediatr Nephrol 2001;16:362-5.
35. Neuhaus TJ, Calonder S, Leumann EP. Heterogeneity of atypical haemolytic uremic syndromes. Arch Dis Child 1997;76:518-21.
36. Niaudet P, Gagnadoux MF, Broyer M, Salomon R. Hemolytic-uremic syndrome: hereditary forms and forms associated with hereditary diseases. Adv Nephrol Necker Hosp 2000;30:261-80.
37. Noris M, Brioschi S, Caprioli J, Todeschini M, Bresin E, Porrati F, et al. Familial haemolytic uraemic syndrome and an MCP mutation. Lancet 2003;362:1542-7.
38. Noris M, Ruggenenti P, Perna A, Orisio S, Caprioli J, Skerka C, et al. Hypocomplementemia discloses genetic predisposition to hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: role of factor H abnormalities. J Am Soc Nephrol 1999;10:281-93.
39. Ohali M, Shalev H, Schlesinger M, Katz Y, Kachko L, Carmi R, et al. Hypocomplementemic autosomal recessive hemolytic uremic syndrome with decreased factor H. Pediatr Nephrol 1998;12:619-24.
40. Renaud C, Niaudet P, Gagnadoux MF, Broyer M, Habib R. Haemolytic uraemic syndrome: prognostic features in children over 3 years of age. Pediatr Nephrol 1995;9:24-9.
41. Repetto HA. Epidemic hemolytic-uremic syndrome in children. Kidney Int 1997;52:1708-19.
42. Rougier N, Kazatchkine MD, Rougier JP, Fremeaux-Bacchi V, Blouin J, Deschenes G, et al. Human complement factor H deficiency associated with hemolytic uremic syndrome. J Am Soc Nephrol 1998;9:2318-26.
43. Siegler R. Spectrum of extrarenal involvement in postdiarrheal hemolytic-uremic syndrome. J Pediatr 1994;125:511-8.
44. Spizzirri FD, Rahman RC, Bibiloni N, Ruscasso JD, Amoreo OR. Childhood hemolytic uremic syndrome in Argentina: long-term follow-up and prognostic features. Pediatr Nephrol 1997;11:156-60.
45. Tonshoff B, Sammet A, Sanden I, Mehls O, Waldherr R, Scharer K. Outcome and prognostic determinants in the hemolytic uremic syndrome of children. Nephron 1994;68:63-70.
46. Trompeter RS, Schwartz R, Chantler C, Dillon MJ, Haycock GB, Kay R, et al. Haemolytic uraemic syndrome: an analysis of prognostic features. Arch Dis Child 1983;58:101-5.
47. Tsai H, Lian E. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998;339:1585-94.
48. Vermelen HM, Karch H, Brandis M, Zimmerhackl LB. Enterohemorrhagic Escherichia coli infections: following transmission routes. Pediatr Nephrol 2000;14:73-83.
49. Veyradier A, Obert B, Haddad E, Cloarec S, Nivet H, Foulard M, et al. Severe deficiency of the specific von Willebrand factor-cleaving protease (ADAMTS 13) activity in a subgroup of children with atypical hemolytic uremic syndrome. J Pediatr 2003;142:310-7.
50. Warwicker P, Goodship TH, Donne RL, Pirson Y, Nicholls A, Ward RM, et al. Genetic studies into haemolytic uraemic syndrome. Kidney Int 1998;53:836-44.
51. Warwicker P, Donne RL, Goodship JA, Goodship TH, Howie AJ, Kumararatne DS, et al. Familial relapsing haemolytic uraemic syndrome and complement factor H deficiency. Nephrol Dial Transplant 1999;14:1229-33.
52. Wong CS, Jelacic S, Habeeb RC, Watkins SL. Tarr PI. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli 0157: H7 infections. N Engl J Med 2000;342:1930-6.
53. Ying L, Katz Y, Schlesinger M, Carmi R, Shalev H, Haider N, et al. Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome. Am J Hum Genet 1999;65:1538-46.